Induction of immunological tolerance by porcine liver allografts.

PubWeight™: 5.89‹?› | Rank: Top 1%

🔗 View Article (PMID 4894426)

Published in Nature on August 02, 1969

Authors

R Y Calne, R A Sells, J R Pena, D R Davis, P R Millard, B M Herbertson, R M Binns, D A Davies

Articles citing this

(truncated to the top 100)

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med (2003) 3.05

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48

Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol (2010) 2.38

Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med (1978) 1.95

Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci U S A (2011) 1.89

Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Tissue-specific expression of an unusual H-2 (class I)-related gene. Proc Natl Acad Sci U S A (1982) 1.76

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med (2008) 1.76

Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74

Mechanisms of drug-induced liver injury. AAPS J (2006) 1.65

Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63

Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus. Proc Natl Acad Sci U S A (1984) 1.58

Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest (2013) 1.57

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Hepatic gene transfer as a means of tolerance induction to transgene products. Curr Gene Ther (2009) 1.54

The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest (2004) 1.53

Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation (1995) 1.51

The immunology of experimental liver transplantation in the rat. Immunology (1985) 1.45

Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology (2011) 1.44

Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology (2008) 1.41

Transplantation of the liver in man. Br Med J (1970) 1.37

IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol (1998) 1.32

The current status of small bowel transplantation in the UK and internationally. Gut (2005) 1.31

Microanatomy of the liver immune system. Semin Immunopathol (2009) 1.22

Liver antigen-presenting cells. J Hepatol (2010) 1.22

Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation (2008) 1.20

Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18

Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation (1994) 1.16

Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol (2008) 1.10

Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation (2012) 1.09

Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07

The activation state of human intrahepatic lymphocytes. Clin Exp Immunol (2007) 1.06

In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation (1995) 1.06

Survival after orthotopic liver transplantation: a follow-up report of two patients. Br Med J (1970) 1.06

Immune tolerance in liver disease. Hepatology (2014) 1.05

Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads. J Immunol (2009) 1.04

Direct, help-independent priming of CD8+ T cells by adeno-associated virus-transduced hepatocytes. Hepatology (2010) 1.02

PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant (2009) 1.00

Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol (2012) 1.00

Differences between pig tissues in the expression of major transplantation antigens: possible relevance for organ allografts. J Exp Med (1976) 1.00

Cellular immunology in the pig. Proc R Soc Med (1973) 1.00

Liver immunology. Compr Physiol (2013) 0.99

NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol (2009) 0.99

Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97

Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J Immunol (2012) 0.96

Tolerance: an overview and perspectives. Nat Rev Nephrol (2010) 0.95

Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

Development of Gene Transfer for Induction of Antigen-specific Tolerance. Mol Ther Methods Clin Dev (2014) 0.93

Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO. J Immunol (2012) 0.92

Stable transfer and restricted expression of a cloned class I gene encoding a secreted transplantation-like antigen. Mol Cell Biol (1985) 0.91

Explanation for loss of the HLA matching effect. Transplant Proc (1995) 0.91

History of clinical transplantation. World J Surg (2000) 0.91

Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg (2000) 0.90

The fas and fas ligand pathways in liver allograft tolerance. Clin Exp Immunol (1999) 0.89

Liver transplants contribute to their own success. Nat Med (1996) 0.89

Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol (2009) 0.88

Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol (2016) 0.88

DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability. J Immunol (2011) 0.87

Combined transplantation of the heart and liver. Ann Surg (1985) 0.87

Induction of unresponsiveness to major transplantable organs in adult mammals: a recapitulation of ontogeny by irradiation and bone marrow replacement. Ann Surg (1979) 0.87

An autoantibody-like factor reactive with liver parenchymal cells in the serum of the pig. Clin Exp Immunol (1971) 0.87

Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology (1985) 0.87

The liver works as a school to educate regulatory immune cells. Cell Mol Immunol (2013) 0.86

Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation. Br J Haematol (2011) 0.86

Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system. PLoS One (2009) 0.86

Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. Proc Natl Acad Sci U S A (2013) 0.86

Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver Int (2015) 0.86

Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol (2016) 0.85

Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1. J Leukoc Biol (2013) 0.85

Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol (1994) 0.85

Development of murine hepatic NK cells during ontogeny: comparison with spleen NK cells. Clin Dev Immunol (2011) 0.85

Regulatory T Cells Control Immune Responses through Their Non-Redundant Tissue Specific Features. Front Immunol (2013) 0.84

Cotransplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide synthase. Transplantation (2014) 0.84

The transcriptomic response of rat hepatic stellate cells to endotoxin: implications for hepatic inflammation and immune regulation. PLoS One (2013) 0.84

Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway. Transplantation (2013) 0.84

Early tolerance in pediatric liver allograft recipients. J Pediatr Surg (1994) 0.84

Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology (1995) 0.83

Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. J Clin Invest (1993) 0.83

Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant (2008) 0.83

Clinical transplantation: current problems, possible solutions. Philos Trans R Soc Lond B Biol Sci (2005) 0.83

Migration of donor cells into the thymus is not essential for induction and maintenance of systemic tolerance after liver transplantation in the rat. Immunology (1995) 0.83

Combined small bowel and reduced auxiliary liver transplantation: case report. World J Gastroenterol (2002) 0.82

Nuclear antigens and auto/alloantibody responses: friend or foe in transplant immunology. Clin Dev Immunol (2013) 0.82

Interferon-γ facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance. J Exp Med (2016) 0.82

Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation (2002) 0.81

Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation (1998) 0.81

Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha. PLoS One (2007) 0.81

Transfer of specific immunosuppression of graft rejection using lymph from tolerant liver-grafted rats. Immunology (1985) 0.81

Articles by these authors

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29

Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10

Elective ventilation of potential organ donors. BMJ (1995) 5.50

The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet (1998) 5.25

Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation (1979) 5.12

The case for "presumed consent" in organ donation. International Forum for Transplant Ethics. Lancet (1998) 4.99

Plasmodium vivax resistance to chloroquine? Lancet (1989) 4.51

Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J (1998) 4.46

Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38

Should organs from patients in permanent vegetative state be used for transplantation? International Forum for Transplant Ethics. Lancet (1997) 4.04

The effects of HIV/AIDS intervention groups for high-risk women in urban clinics. Am J Public Health (1994) 3.37

Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09

Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04

Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98

A new technique for biliary drainage in orthotopic liver transplantation utilizing the gall bladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg (1976) 2.86

Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography. J Exp Med (1967) 2.86

Mouse histocompatibility isoantigens derived from normal and from tumour cells. Immunology (1966) 2.84

Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67

Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57

Liver transplantation. Curr Probl Surg (1979) 2.57

Rapamycin for immunosuppression in organ allografting. Lancet (1989) 2.51

Orthotopic liver transplantation: the first 60 patients. Br Med J (1977) 2.50

Soluble HLA antigens in the circulation of liver graft recipients. Transplantation (1989) 2.48

A surgical experience with five hundred thirty liver transplants in the rat. Surgery (1983) 2.48

Some personal observations on the university department of surgery. Ann R Coll Surg Engl (1977) 2.46

Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother (1984) 2.40

Solubilization and partial purification of mouse histocompatibility antigens from a membranous lipoprotein fraction. Proc Natl Acad Sci U S A (1966) 2.33

Ninety-seven million years of angiosperm-insect association: paleobiological insights into the meaning of coevolution. Proc Natl Acad Sci U S A (1994) 2.32

Production of an H--2-related suppressor factor by a hybrid T-cell line. Nature (1979) 2.22

Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation (1980) 2.21

Prolonged survival of liver transplants in the pig. Br Med J (1967) 2.14

Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA (1995) 2.12

Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10

Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases. Transplantation (1977) 2.08

Bone marrow and lymphoid cell injection of the pig foetus resulting in transplantation tolerance or immunity, and immunoglobulin production. Nature (1967) 2.04

Liver transplantation in man: the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology (1973) 1.99

Transplant surgery: current status. Br J Surg (1980) 1.95

Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94

Bile composition and bile cast formation after transplantation of the liver in man. Transplantation (1975) 1.92

A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol (1992) 1.92

Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ (1992) 1.90

Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ (1990) 1.88

Patterns of non-response to a mail survey. J Clin Epidemiol (1990) 1.87

Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med (1970) 1.83

Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol (1977) 1.83

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol (1994) 1.80

Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol (1994) 1.75

AIDS/HIV risk behavior among the chronic mentally ill. Am J Psychiatry (1992) 1.72

Gastrointestinal complications after renal transplantation. Lancet (1971) 1.71

Stabilization of the anticodon stem-loop of tRNALys,3 by an A+-C base-pair and by pseudouridine. J Mol Biol (1999) 1.70

Observations of orthotopic liver transplantation in the pig. Br Med J (1967) 1.69

Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68

Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients. Br Med J (1968) 1.68

Liver transplantation. Transplant Rev (1969) 1.67

Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67

Outcome of HIV infection in transplant patient on cyclosporin. Lancet (1991) 1.66

Combined mediastinal and retroperitoneal fibrosis. Lancet (1966) 1.66

Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med (1982) 1.64

Controlled clinical trial comparing early with interval cholecystectomy for acute cholecystitis. Br J Surg (1975) 1.63

Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats. Surg Gynecol Obstet (1988) 1.60

Organisation of the lymphoreticular system and lymphocyte markers in the pig. Vet Immunol Immunopathol (1982) 1.60

Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (1988) 1.60

Physical activity and self-reported, physician-diagnosed osteoarthritis: is physical activity a risk factor? J Clin Epidemiol (2000) 1.59

Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease. Lancet (1990) 1.57

Administration of heparin and antibiotic prophylaxis. Br J Surg (1994) 1.55

Cellular immune response during rejection of a liver transplant in man. Nature (1969) 1.55

Observations on preservation, bile drainage and rejection in 64 human orthotopic liver allografts. Ann Surg (1977) 1.53

The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation (1988) 1.51

Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J Nucl Med (1994) 1.51

Hypermodified nucleosides in the anticodon of tRNALys stabilize a canonical U-turn structure. Biochemistry (2000) 1.51

Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation (2004) 1.51

The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia (1987) 1.47

Gross reactivity between synthetic T,GA-L and transplantation antigens in CBA Mice. Nat New Biol (1973) 1.46

Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin. Br Med J (1978) 1.46

Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol (1993) 1.43

The nails in adult type 1 pityriasis rubra pilaris. A comparison with Sézary syndrome and psoriasis. J Am Acad Dermatol (1986) 1.43

Synthesis and studies on the effect of 2-thiouridine and 4-thiouridine on sugar conformation and RNA duplex stability. Nucleic Acids Res (1997) 1.42

Plasma lipids following renal transplantation. Transplantation (1973) 1.42

Recent military experience with malaria chemoprophylaxis. Med J Aust (1993) 1.41

Conformational flexibility in RNA: the role of dihydrouridine. Nucleic Acids Res (1996) 1.41

Live organs from dead people. J R Soc Med (1979) 1.40

Cadaveric kidneys for transplantation. Br Med J (1969) 1.39

Successful use of size-mismatched liver allografts in children by delayed primary closure of the abdominal wall. Br J Surg (1996) 1.39

Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report. Br Med J (1980) 1.38

Mucosal characteristics of pelvic ileal pouches. Gut (1991) 1.38

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY: ABNORMAL SPLITTING OF ETHYL GROUPS DUE TO MOLECULAR ASSYMETRY. Proc Natl Acad Sci U S A (1961) 1.38

A cardinal role for I-region antigens (Ia) in immunological enhancement, and the clinical implications. Transplant Rev (1976) 1.35

Immunosuppressive effects of the orthotopically transplanted porcine liver. Transplant Proc (1969) 1.34